ADIM
BSX icon

Alpha DNA Investment Management’s Boston Scientific BSX Stock Holding History

Alpha DNA Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,078
Closed -$811K – 35
2024
Q4 		$811K Sell
9,078
-1,245
-12% -$110K 0.31% 65
2024
Q3 		$865K Sell
10,323
-281
-3% -$22.2K 0.32% 66
2024
Q2 		$817K Buy
+10,604
New +$776K 0.32% 69

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alpha DNA Investment Management's BSX Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 9,078 shares — an estimated $811K sold.

Alpha DNA Investment Management first reported a position in BSX in Q2 2024 and held it in 3 quarters. The position peaked at $865K in Q3 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,078 Boston Scientific shares in Q1 2025, an estimated $811K.
  • Alpha DNA Investment Management first reported a position in Boston Scientific in Q2 2024 and held it in 3 quarters.
  • Alpha DNA Investment Management's Boston Scientific position peaked at $865K in Q3 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.